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implementation of the ACA in early 2014. In terms of
Medicaid problems, the survey found that transplant cen-
ters have considerable issues with Medicaid reimbursement
rates (45%), prior authorization issues (46%), beneﬁt re-
strictions (38%) and coverage for speciﬁc clinical indications
(32%). Transplant centers issues with Medicare centered on
coverage for certain indications (71%) with some concern for
the current Medicare reimbursement rate (30%). Commer-
cial payers were rated by transplant centers to have minor
(32%) or some issues (43%) when it comes to the scope of
overall issues transplant centers face. Respondents gave
qualitative responses about how the ACA is impacting their
transplant center and patient populations. While a few re-
spondents provided positive anecdotes about expanded
patient access to care through the ACA, many respondents
discussed network inclusion issues, problems with home
health care, beneﬁt confusion and sincere concerns with
pharmaceutical beneﬁt restrictions. The survey results will
direct the efforts of the NMDP’s Payer Policy team and help
to inform the transplant community about common payer
challenges.531
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The establishment of a Quality Management System (QMS)
according to FACT e JACIE standards in a BMTcenter is a very
laborious project. Involvement of all personnel implicated in
collection, processing and clinical procedures is absolutely
necessary. Involvement includes strategic scheduling of QMS
development, writing of SOPs and documents, and imple-
mentation of the system. Deviations from the system as er-
rors, accidents and adverse reactions are very important to
be reported in a way to make corrections and improvement
in the system.
In our BMT center the duration of the task from the
beginning to the application for JACIE accreditation was four
years. A team of QM specialists was hired to work for the
common project. Doctors, nurses, technicians and the QM
specialists attended JACIE courses for center preparation.
Writing of SOPs and documents was shared between the
different departments. The QMS was implemented for the
ﬁrst time in June 2012. Audit of JACIE inspectors was per-
formed in March 2013 and the center was fully accredited in
October 2013.
During this task the personnel of the center acquired a lot
of experience regarding SOP management especially in the
ﬁeld of deviations from the system. Errors, accidents and
adverse reactions were completely reported and internal
audits were for this purpose. Following the incidences in
the three different phases: 1) organizing the QMS, 2)
implementation e JACIE inspection and 3) post-inspection
we realized that the number of deviations reported wascompletely different. There was an increase in the number
of deviations reported during the second phase starting at
the implementation and getting a peak during JACIE in-
spection. There was a 3fold increase compared to phase 1.
During the 3rdphase the number of deviations reported
has decrease and it is in a 2fold lower level compared to
the peak phase 2. Internal audits and inspections have
documented that this is due to corrections and improve-
ments of the system and the behavior of the personnel
and not due to relaxing which is an achievement for our
center.
In conclusion recording and dealing with adverse events as
well as reducing the actual number of deviations, as a result
of the better training and programming, could be a major
factor that improves the safety level.532
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Through the multi-year System Capacity Initiative and in
collaboration with hematopoietic cell transplant (HCT)
experts and key stakeholders, National Marrow Donor
Program/Be The Match evaluated the impact of work-
force and infrastructure challenges on the utilization of
HCT. A key ﬁnding from the needs assessments (Majhail et
al. BBMT, 2012; Denzen, et al. BBMT, 2013) was that the
effectiveness of recruitment and retention efforts is
limited by work-related distress (e.g., burnout, moral
distress, and compassion fatigue) across the HCT work-
force. Although a recent evaluation by Shanafelt et al. (JCO,
2014) identiﬁed a burnout rate of 44.7% in almost 3000
Figure 1. IICT Multidisciplinary Care Teams Survey domains
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of the prevalence and etiology of burnout within HCT to
date. We hypothesize that the issues of burnout, moral
distress and compassion fatigue are prevalent among HCT
health professionals. Second, we hypothesize that lower
level functioning in these areas, along with poor work-life
balance, correlate with career dissatisfaction in HCT pro-
fessionals. To test this, we will conduct a cross-sectional,
web-based survey focused on ﬁve measurement domains
and utilizing two validated scales: Maslach Burnout In-
ventory and Moral Distress Scale-Revised (Figure 1). Par-
ticipants will be recruited from special interest groups
within professional societies/associations representing ﬁve
HCT disciplines: nurses, nurse practitioners/physician as-
sistants, pharmacists, physicians and social workers. With
a target sample size of 6,000, this will be the ﬁrst
comprehensive, prospective study of the HCT multidisci-
plinary care team. Results describing the prevalence of
work-related distress and its association with career
satisfaction, controlling for demographic and work-envi-
ronment characteristics, will be presented and used to
design future interventions.PHARMACY
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Posterior reversible encephalopathy syndrome (PRES) is a
neuroclinical and radiological syndrome that commonly
consists of parietooccipital and posterior frontal cortical and
subcortical edema. The neurologic manifestations are vari-
able, but frequently include headache, altered mental status,
visual disturbances and seizures. Known associated causa-
tive agents include calcineurin inhibitor immunosuppres-
sives such as tacrolimus and cyclosporine.
We herein report a case of 12 years old boy that was diag-
nosed with fanconi anemia and underwent allogeneic He-
matopoietic Stem Cells Transplantation (HSCT) with
ﬂudarabine (35 mg/m2/day x5), cyclophosphamide (10 mg/
m2/day x4) and anti-thymocyte globulin (Rabbit ATG) (2.5
mg/kg/day x4). GVHD prophylaxis included cyclosporine (65
mg/m2/dose BID) starting day -3 and mycophenolate mofetil
600 mg/m2/dose BID) starting on day 0. Pre stem cells infu-
sion course was complicated with ICU admission due to ATG
anaphylaxis reaction. Post stem cells infusion, the patient
had elevated blood pressure and experienced seizure. MRI
brain conﬁrmed PRES. Cyclosporine was discontinued. Pa-
tient was put on methylprednisolone 2 mg/kg for GVHD
prophylaxis. The patient did not experience any seizure
afterwards. PRES resolved based on follow up imaging. The
patient was started on tacrolimus with no further PRES
episodes.
Although it is a rare complication, it can be concluded that
PRES should be suspected with neurological symptoms in
children undergoing HSCT and taking a calcineurin inhibitor.
If conﬁrmed by imaging, rigorous control of arterial blood
pressure and discontinuation of the offending agent is rec-
ommended.We also conclude that it’s safe to rechallenge the
